ArticleSmall science2021
High-Efficient and Dosage-Controllable Intracellular Cargo Delivery through Electrochemical Metal-Organic Hybrid Nanogates.
Article in Small science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- An integrated nanopore-microfluidic platform for low-voltage electroporation of delivering self-amplifying RNA into dendritic cells.Microsystems & nanoengineering · 2026Article
- A Nanotube Injector for Cytoplasmic Transfer and Enhanced Mitochondrial Function.Small science · 2026Article
- Recent advances in redox-responsive nanoparticles for combined cancer therapy.Nanoscale advances · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hollow nanostructures combined with electroporation are potentially valuable in interdisciplinary fields due to their ability to transport versatile cargos into adhesive cells. However, they require voltages over 1.5 V to electroporate the physical barrier of the cell membrane inducing cell death and differentiation processes. Intracellular delivery is exhibited using a metal-organic hybrid nanotube (NT) stamp that physically inserts into the cells and subsequently injects versatile molecules at an extremely low voltage of ±50 mV (less than membrane potential). The hybrid NTs consist of Au NTs polymerizing electrochemically 3,4-ethylenedioxythiophene monomer and supportive polycarbonate membrane. The hybrid stamp improves the cell viability by 94% for a 30 min physical insertion while decreasing the cell viability to 1% using the original Au NTs. Furthermore, the hybrid stamp acts as an electrochemical gate that can open the pore at ±50 mV to transport small molecules of calcein dye with high efficiency (99%) and viability (96.8%). The hybrid nanogate can also transport large molecules of green fluorescent protein (GFP) with 84% efficiency and 98.5% viability, and GFP plasmid at a transfection rate of ≈10%. Thus, the present hybrid stamping can potentially deliver versatile molecules into adhesive cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.